John Crowley
Chief Executive Officer at Biotechnology Innovation Organization
Net worth: 8 M $ as of 31/03/2024
Profile
Founder of Amicus Therapeutics, Inc., Orexigen Therapeutics, Inc. and Novazyme Pharmaceuticals, Inc., John Francis Crowley is Chairman & Chief Executive Officer of Amicus Therapeutics, Inc. Mr. Crowley is also on the board of 6 other companies. In the past he was Director-Business Strategy at Bristol Myers Squibb Co., President & Chief Executive Officer at Orexigen Therapeutics, Inc., President & Chief Executive Officer at Novazyme Pharmaceuticals, Inc., Litigation Associate-Health Care Practice Group at Bingham Summers Welsh & Spilman, Senior Vice President of Genzyme Therapeutics Ltd. and National Chairman at Make-A-Wish Foundation of America. He received an undergraduate degree from Georgetown University, a graduate degree from the University of Notre Dame The Law School and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/03/2024 | 638,373 ( 0.22% ) | 8 M $ | 31/03/2024 | |
ENTRADA THERAPEUTICS INC
0.11% | 08/06/2023 | 36,496 ( 0.11% ) | 517 148 $ | 31/03/2024 |
| 14/06/2023 | 11,716 ( 0.01% ) | 322 307 $ | 31/03/2024 |
John Crowley active positions
| Companies | Position | Start |
|---|---|---|
St. Peter's University Hospital
 St. Peter's University Hospital Medical/Nursing ServicesHealth Services St. Peter's University Hospital provides healthcare services. The firm offers addiction recovery, bariatric surgery, cancer care, and family health center services. The company was founded in 1872 and is headquartered in New Brunswick, NJ. | Director/Board Member | 23/11/2010 |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | President | - |
| University of Notre Dame | Director/Board Member | - |
Global Genes
 Global Genes Miscellaneous Commercial ServicesCommercial Services Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin. | Director/Board Member | - |
| The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Chief Executive Officer | 04/03/2024 |
Former positions of John Crowley
| Companies | Position | End |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Chief Executive Officer | 01/08/2022 |
| ENTRADA THERAPEUTICS, INC. | Director/Board Member | 05/12/2023 |
| INTELLIA THERAPEUTICS, INC. | Director/Board Member | 05/12/2023 |
| ░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of John Crowley
| Georgetown University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| University of Notre Dame The Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | Health Technology |
| Bingham Summers Welsh & Spilman | Commercial Services |
Novazyme Pharmaceuticals, Inc.
 Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK. | Commercial Services |
Make-A-Wish Foundation of America
 Make-A-Wish Foundation of America Miscellaneous Commercial ServicesCommercial Services Make-A-Wish Foundation of America operates as a charitable organization. It serves child diagnosed with a life-threatening medical condition. The company was founded by Allan Schmidt, Kathy McMorris, and Tommy Austin in 1980 and is headquartered in Phoenix, AZ. | Commercial Services |
St. Peter's University Hospital
St. Peter's University Hospital Medical/Nursing ServicesHealth Services St. Peter's University Hospital provides healthcare services. The firm offers addiction recovery, bariatric surgery, cancer care, and family health center services. The company was founded in 1872 and is headquartered in New Brunswick, NJ. | Health Services |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
| The Wall Street Journal CEO Council | |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin. | Commercial Services |
| Entrada Therapeutics, Inc. |
- Stock Market
- Insiders
- John Crowley
